expressed in neurons throughout the central nervous system (2) (3) (4) . Binding of BDNF to TrkB results in phosphorylation of tyrosine residues in the cytoplasmic domain of the receptor (5) and subsequent recruitment and activation of various signaling proteins, including Shc, Gab1, FRS-2, and SH2-B (6 -9) . Such signaling proteins may link Trk activation to Ras and the downstream activation of mitogen-activated protein kinases (MAPKs) and the phosphatidylinositol 3-kinase (PI3K)-Akt kinase pathway (10 -13) . MAPK and Akt kinase have been reported to promote the survival of neurons in various physiological and pathological settings (14 -20) .
Calcium is a second messenger that mediates a variety of physiological responses of neurons to neurotransmitters and neurotrophic factors, including cell survival responses (14, (21) (22) (23) (24) (25) (26) ). An increase in cytoplasmic calcium levels can activate Ras, resulting in the activation of Raf, MEK, and MAPKs (27, 28) ; and calcium can also activate the PI3K-Akt pathway (14) . BDNF has several effects on cellular calcium homeostasis, including enhancement of calcium oscillations in cultured hippocampal neurons (29) and stimulation of calcium release from inositol 1,4,5-trisphosphate-sensitive stores in myocytes (30) . In addition, studies have suggested roles for calcium/calmodulindependent protein kinase (CaMK) IV in the effects of BDNF on gene expression (31) . However, it is not known if and how calcium mediates survival signaling by BDNF.
Calmodulin is a loop-helix-loop Ca 2ϩ -binding protein that is evolutionarily conserved and is expressed in all mammalian cells (32) . Calmodulin transduces Ca 2ϩ signals by interacting with specific target proteins; examples include CaMKII, CaMKIV, calcineurin, spectrin A2, p21, and neuronal nitricoxide synthase (33, 34) . Calmodulin has four Ca 2ϩ -binding sites, with two in the globular N-terminal domain and two in the globular C-terminal domain; the Ca 2ϩ -binding sites are separated by flexible ␣-helical domains. When bound to Ca 2ϩ , calmodulin undergoes a conformational change that allows it to bind to target effector proteins and to stimulate or inhibit their activities. Calmodulin plays important roles in regulating synaptic plasticity (35) , but its possible roles in mediating actions of neurotrophic factors are unknown. Because BDNF has been shown to increase the levels of intracellular Ca 2ϩ in neurons on the one hand and also activates PI3K-Akt and Ras-MEK-MAPK pathways on the other hand, we sought to establish a * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
role for calmodulin in one or both of these BDNF cell survival signaling pathways.
MATERIALS AND METHODS

Neocortical Cell Cultures and Experimental
Treatments-Cultures of embryonic neocortex were prepared from embryonic day 18 SpragueDawley rats as described previously (36) . Cells were plated at a density of 50,000 cells/cm 2 on 12-mm glass coverslips photoetched with a grid (Eppendorf) to allow relocation of the same microscope field at different time points. The coverslips were coated with poly-L-lysine (Sigma). The culture medium consisted of Neurobasal medium with B27 supplements (Invitrogen); cultures were maintained in a 95% room air and 5% CO 2 humidified atmosphere at 37°C. BAPTA-AM and EGTA were from Molecular Probes, Inc. BDNF was from Invitrogen. W-12, W-13, clastolactacystin ␤-lactone, KN-92, KN-93, and AIP were from CalbiochemNovabiochem. LY294002 and PD98059 were from Cell Signaling Technology. Nicardipine was from Sigma.
Viral Vectors-Site-directed mutagenesis was performed by PCR using the overlap extension method (37) . A synthetic gene encoding wild-type bovine calmodulin (38) were all changed to Ala. A 5Ј-flanking BamHI restriction site and a 3Ј-flanking EcoRI restriction site were introduced into the wild-type and mutant calmodulin cDNAs. DNA fragments (BamHI-EcoRI) containing the entire coding region of wild-type or mutant calmodulin were first subcloned into the pGEX-4T plasmid. DNA fragments (HindIII-XbaI) containing the wild-type or mutant calmodulin cDNA were then removed from the pGEX-4T plasmid and subcloned into the adenoviral shuttle plasmid pAdv/RSV (39) . A portion of each construct (15 g ) and an equal amount of the adenoviral package plasmid pJM17 were cotransfected into the E1 transcomplementing cell line 293 using calcium phosphate. The recombinant adenoviruses, generated by homologous recombination, were isolated by plaque formation in 293 cells. Viral DNA was isolated from at least five separate plaques for each construct, and the insertion of calmodulin or its mutants or ␤-galactosidase in the viral genome was confirmed by restriction endonuclease digestion. High-titer stocks of recombinant adenoviruses were grown in 293 cells and purified by density gradient ultracentrifugation. The titers of viral stocks were ϳ2.8 ϫ 10 9 pfu/ml for wild-type calmodulin, 6 ϫ 10 9 pfu/ml for CaM(1,2), 4.4 ϫ 10 9 pfu/ml for CaM(3,4), 3 ϫ 10 9 pfu/ml for CaM(1-4), and 4.8 ϫ 10 9 pfu/ml for ␤-galactosidase. The methods for delivery of the adenovirus to the cultures were described previously (40) . The cultured neurons were infected at a multiplicity of infection of 50 pfu/cell.
Immunohistochemistry-At 8 days in culture, the cells were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature and then washed with PBS. The fixed cells were permeabilized with 0.2% Triton X-100 for 10 min, followed by a 2-h incubation at room temperature in blocking solution (5% normal goat serum and 0.2% Triton X-100 in PBS, pH 7.4) containing primary monoclonal antibody against MAP2, a microtubule-associated protein used as neuronal marker. After washing with PBS, cells were incubated for 2 h in PBS containing fluoresceinconjugated goat anti-mouse IgG (1:200; ImmunoResearch Laboratory). After washing with PBS, some cultures were counterstained with propidium iodide (10 g/ml), a DNA-binding dye, to label nuclei.
␤-Galactosidase Staining-After 3 days of infection with adeno-␤-galactosidase, the cells were rinsed briefly in ice-cold PBS and incubated for 1 h in fixative solution (2% formaldehyde, 0.2% glutaraldehyde, and 0.1 M NaHPO 4 , pH 7.3). Cells were washed three times with rinse solution (0.01% sodium deoxycholate, 0.02% Nonidet P-40, 2 mM MgCl 2 , and 0.1 M NaHPO 4 , pH 7.3) and then placed in X-gal stain solution containing 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , and 5 mM K 4 Fe(CN) 6 plus 0.1 M NaHPO 4 , pH 7.3, 0.01% sodium deoxycholate, 0.02% Nonidet P-40, and 8 mg/ml X-gal for 12-16 h at 37°C. Stained cells were rinsed and equilibrated in sucrose solution (20% sucrose, 0.05% NaN 3 , and 0.1 M NaHPO 4 , pH 7.3) at 4°C.
Evaluation of Neuronal Survival-At 5 days in vitro, live neurons in each of four 175-m 2 regions of the grid on each coverslip were counted from images captured using a digital camera; at the beginning of each experiment, the average number of neurons in a 175-m 2 region was in the range of 30 -50. Four separate coverslips were used for each condition; and thus, ϳ800 neurons were quantified for each experiment. Four separate experiments were performed. Neurons that were in the process of degenerating (i.e. that displayed nuclear condensation, membrane blebbing, and extensive neurite fragmentation) were excluded. On each subsequent day, the same areas were located and recounted; the number of live neurons remaining at each day was expressed as a percentage of the initial number. To identify and quantify apoptotic neurons, cells were fixed in 4% paraformaldehyde in PBS and then stained with the DNA-binding dye Hoechst 33258. Coverslips were mounted onto glass slides and examined under epifluorescence illumination using a ϫ40 objective lens. Cells were considered ''apoptotic'' if their nuclear chromatin was condensed or fragmented, whereas cells were considered viable if their chromatin was diffusely and evenly distributed throughout the nucleus.
To further confirm and detect apoptotic DNA fragmentation, a TUNEL kit (R&D Systems) was used. Briefly, the cells were fixed with 4% paraformaldehyde in PBS for 30 min and washed with PBS, pH 7.4. After blocking of endogenous peroxidases, the cells were incubated at 37°C for 1 h in a reaction mixture containing terminal transferase, biotinylated nucleotide (dNTP), or PBS as a control. Cells were then incubated in the presence of streptavidin-conjugated horseradish peroxidase for 20 min at room temperature. After rinsing in PBS, DNA strand breakage was visualized in the presence of horseradish peroxidase substrate. The apoptotic cells exhibited dark blue nuclear staining. Approximately 500 cells on each coverslip were scored; three separate coverslips were assessed for each condition in each experiment; and three separate experiments were performed for both Hoechst 33258 staining and TUNEL staining.
Immunoblot Analysis-After infection and experimental treatment, the cells were solubilized in SDS-PAGE sample buffer, and the protein concentration in each sample was determined using a Bio-Rad protein assay kit with bovine serum albumin as the standard. Proteins (50 g of protein/lane) were then resolved on 7.5-12% SDS-polyacrylamide gels and electrophoretically transferred to a nitrocellulose membrane. Membranes were blocked with 4% nonfat milk in Tris-HCl-based buffer with 0.2% Tween 20, pH 7.5, and then incubated overnight at 4°C in the presence of primary antibody. Cells were incubated for 1 h in the presence of a 1:5000 dilution of secondary antibody (IgG) conjugated to horseradish peroxidase. Reaction product was visualized using an enhanced chemiluminescence Western blot detection kit (ECL, Amersham Biosciences). The primary antibodies included anti-tubulin (mouse, 1:5000; Sigma), anti-phospho-p42/44 MAPK (mouse, 1:1000; New England Biolabs Inc.), anti-p42/44 MAPK (rabbit, 1:1000; New England Biolabs Inc.), anti-phospho-Akt (rabbit, 1:1000; Cell Signaling Technology), anti-Akt (rabbit, 1:1000; Cell Signaling Technology), and anticalmodulin (mouse, 1:1000; Upstate Biotechnology, Inc.).
Statistics-All data are presented as means Ϯ S.E. Comparisons between controls and treatments were performed using Student's unpaired t test or ANOVA when appropriate. A value of p Ͻ 0.05 was considered to be statistically significant.
RESULTS
Calcium-binding Domains 3 and 4 of Calmodulin Are Required for the Long-term Survival of Neocortical Neurons-To
investigate how calmodulin, a calcium-sensing protein, can influence neuronal survival, we used primary neocortical neurons that were isolated and cultured from embryonic day 18 Sprague-Dawley rats in serum-free medium. The cultures consisted of two populations of cells (based on morphology and expression of cell type-specific proteins). Cells with round cell bodies and long thin neurites were immunoreactive with an antibody against MAP2, whereas flat cells with no neurites were immunoreactive with an antibody against glial fibrillary acidic protein (Fig. 1 , A-C; and data not shown). At 8 days in culture, 91 Ϯ 3.3% (n ϭ 3) of the cells were MAP2-positive and 9 Ϯ 4.5% (n ϭ 3) were MAP2-negative, whereas at 14 days in culture, the percentage of MAP2-negative cells was increased to ϳ25%. The distinct morphologies of neurons and astrocytes allowed us to unambiguously identify neurons for the various analyses performed in this study.
To study the role of calmodulin in neuronal survival, we performed site-directed mutagenesis to generate forms of calmodulin in which either Ca 2ϩ -binding domains 1 and 2 (CaM(1,2)) or 3 and 4 (CaM(3,4)) or all four Ca 2ϩ -binding domains (CaM(1-4)) were mutated at Asp residues known to be critical for Ca 2ϩ binding (Asp 21 , Asp 57 , Asp 94 , and Asp 130 ); in each case, the mutation changed the Asp residue to an Ala residue. Adenoviral constructs were used to deliver the calmod-ulin cDNAs into primary neocortical neurons in culture. To control for nonspecific effects of infection and overexpression of any exogenous protein, we used neurons infected with adeno-␤-galactosidase as the control in this study. Using a multiplicity of infection of 50, we found that nearly 100% of the neurons were infected as demonstrated by ␤-galactosidase staining (Fig. 1C) . Immunoblot analysis of cell lysates showed that the CaM(3,4) and CaM(1-4) proteins were overexpressed in infected cells and that, as expected for adenoviral vectors, expression was sustained at a high level (Fig. 1D) . The mutant forms of calmodulin exhibited a slightly lower apparent molecular mass than endogenous calmodulin (Fig. 1B) , consistent with a previous finding that calmodulin displays a Ca 2ϩ -dependent shift in electrophoretic mobility (41) . In a previous study, we found that when cardiac myocytes were infected with adenoviral vector containing wild-type calmodulin or mutant CaM(1,2), the levels of calmodulin were tightly regulated such that little or no overexpression of calmodulin occurred. 2 We obtained a similar result in primary neocortical neurons infected with adenovirus containing wild-type calmodulin or mutant CaM(1,2) (Fig. 1D) .
The cells were cultured for 5 days in Neurobasal medium with B27 supplements and then infected with adeno-␤-galactosidase (control), adeno-CaM(1,2), adeno-CaM(1-4), or adenoCaM(3,4). At 5 days in culture, cells were infected with viral vectors. Three days after infection, the culture medium was changed to Neurobasal medium lacking B27 trophic supplements (withdrawal of trophic support). Fig. 2A shows representative phase-contrast micrographs of cultured cortical neurons that had been infected with adeno-␤-galactosidase and adeno-CaM(1-4) immediately prior to withdrawal of trophic supplements and 4 days later. Many more neurons had degenerated 4 days after withdrawal of trophic support in cultures infected with CaM(1-4) compared with cultures infected with control virus. To quantitatively analyze the time course of neuronal survival, the total number of cells identifiable as live neurons by phase-contrast microscopy in each grid square was counted daily for 6 days. The results show that neuronal survival was significantly decreased in neurons expressing the CaM(3,4) and CaM(1-4) mutants 2, 4, and 6 days after withdrawal of trophic support compared with neurons infected with control virus or virus containing the CaM(1,2) mutant (Fig.  2B) . In an additional experiment, we performed TUNEL staining analysis of adeno-␤-galactosidase-, adeno-CaM(1,2)-, adeno-CaM(1-4)-, or adeno-CaM(3,4)-infected neurons 6 days after withdrawal of trophic support. Essentially all of the neurons expressing CaM (3, 4) or CaM(1-4) were TUNEL-positive, whereas ϳ70% of the neurons expressing ␤-galactosidase (control) or infected with adeno-CaM(1,2) were TUNEL-positive (Fig. 2, C and D) . When trophic support was not removed from the cultures, adeno-CaM(3,4)-and adeno-CaM(1-4)-infected neurons died significantly faster compared with adeno-␤-galactosidase-and CaM(1,2)-infected neurons (Fig. 2, C and  D) . Thus, the CaM(3,4) and adeno-CaM(1-4) mutations promote neuronal death in the absence or presence of trophic support, indicating that the effect of the mutations is not the result of an altered response to one or more components of the B27 supplements.
Evidence That Calmodulin with Functional Calcium-binding Domains 3 and 4 Is Required for the Neuronal Survivalpromoting Activity of BDNF-
The initial results suggested a role for calmodulin in cell survival signaling in developing neocortical neurons. To link calmodulin to a specific trophic factor signaling pathway, we employed BDNF, a neurotrophin previously shown to promote the survival of cultured embryonic hippocampal and neocortical neurons (42) (43) (44) . When cultures that had been infected with the control adenoviral construct or adeno-CaM(1,2) were treated with BDNF after withdrawal of trophic supplements, long-term neuronal survival was significantly increased (Fig. 3A) . In contrast, the ability of BDNF to promote neuronal survival was completely abolished in neurons expressing either the CaM(1-4) or CaM(3,4) mutant (Fig. 3, B and C) , demonstrating that Ca 2ϩ binding in the C-terminal EF-hands of calmodulin is required for BDNF cell survival signaling. To confirm a role for calmodulin in BDNF cell survival signaling, we employed W-13, a calmodulin antagonist, and W-12, a less active structural ana-2 D. Yang, A. Cheng, and R. Xiao, manuscript in preparation. log of W-13 (W-13 IC 50 ϭ 68 M versus W-12 IC 50 ϭ 260 M) (45) . In these experiments, neuronal death was assessed 2 days following withdrawal of trophic supplements by counting Hoechst-stained neurons with condensed nuclei or TUNELpositive cells (Fig. 4A) . In cultures subjected to withdrawal of trophic supplements, ϳ20% of the cells died during a 2-day period, whereas ϳ10% of the cells died when they were treated with BDNF. When cells were treated with 80 M W-13, a concentration previously shown to inhibit calmodulin maximally (14) , the neuronal survival-promoting effect of BDNF was completely abolished (Fig. 4, A and B) . At this concentration, the effect of W-13 was specific because the same concentration of W-12 did not alter the ability of BDNF to prevent apoptotic neuronal death (Fig. 4B) . As was the case when neuronal survival was evaluated in neurons expressing a calmodulin mutant by morphological criteria (Fig. 3) , W-13 completely abolished the ability of BDNF to prevent neuronal death as assessed by counting apoptotic nuclei (Fig. 4, A and B) .
Two pathways for BDNF cell survival signaling in neurons have been identified, one involving PI3K and Akt kinase and the other involving MAPKs p42 and p44 (also known as ERK1 and ERK2) (12, 13). To determine which of these pathways is involved in BDNF cell survival signaling in our neocortical cultures, we pretreated cultures with either LY294002, an inhibitor of PI3K (46), or PD98059, an inhibitor of MEK1 (47) . LY294002 completely abolished the neuronal survival-promoting effect of BDNF, whereas PD98059 did not (Fig. 4B) . In other studies, we found that the same batch of PD98059 could block the activation of ERKs by BDNF (data not shown), suggesting that failure of PD98059 to abolish the neuronal survival-promoting effect of BDNF is not due to instability of PD98059. These results suggest that activation of PI3K is required for BDNF cell survival signaling, whereas activation of ERKs is not.
Calmodulin Activity and Intact Calcium-binding Domains 3 and 4 Are Essential for Activation of Akt Kinase, but Not p42/44
MAPKs, by BDNF-To determine whether calmodulin acts upstream of one or both of the kinase cascades activated by BDNF, we exposed neocortical cultures to BDNF in the absence or presence of the calmodulin antagonist W-13 and then evaluated the activation levels of Akt and ERKs by performing immunoblot analyses of cell lysates using antibodies against the phosphorylated (active) forms of Akt and ERK1/2. The levels of phospho-Akt and phospho-ERK1/2 were greatly in- creased during a 10-min exposure to BDNF (Fig. 5A) . The levels of Akt and ERK proteins were unchanged in neurons exposed to BDNF, thus indicating that the increased levels of phospho-Akt and phospho-ERKs are the result of increased phosphorylation of a constant level of proteins. Treatment of cultures with W-13 largely abolished the ability of BDNF to activate Akt, whereas W-12 had no effect on BDNF-induced activation of this kinase (Fig. 5A) . In contrast, W-13 did not compromise the ability of BDNF to activate ERK1 or ERK2. These results suggest that calmodulin is a pivotal upstream mediator of BDNF-induced Akt activation and cell survival signaling in embryonic neocortical neurons.
We next sought to determine the Ca 2ϩ -binding requirements for activation of Akt and ERKs by calmodulin. The basal levels of Akt phosphorylation were greatly decreased in neurons overexpressing the CaM(1-4) and CaM(3,4) mutants compared with uninfected neurons or neurons infected with control virus or with adeno-CaM(1,2) (Fig. 5, B and C) . Exposure of control cultures to BDNF resulted in a large increase in phospho-Akt levels in neurons infected with control virus or virus containing CaM(1,2); Akt phosphorylation was increased within 10 min of exposure to BDNF, was further increased at 30 min, and remained elevated through 240 min of exposure to BDNF (Fig. 6,  A and B) . In contrast, BDNF did not cause a significant increase in the levels of phospho-Akt in neurons expressing the CaM(1-4) or CaM(3,4) mutant (Fig. 6, A and B) .
We did not observe any significant differences in the levels of calmodulin in neurons expressing adeno-wild-type calmodulin (data not shown), adeno-CaM(1,2), and adeno-␤-galactosidase, apparently because of the tight regulation of the endogenous calmodulin expression levels (Fig. 1D) . We therefore designed experiments to rule out the possibility that the effects of the CaM(3,4) and CaM(1-4) mutants were the result of nonspecific effects of overexpression of the mutant proteins. When the cultures were treated with clasto-lactacystin ␤-lactone (an irreversible 20 S proteasome inhibitor) 48 or 72 h after infection with wild-type calmodulin or mutant CaM(1,2), both wild-type calmodulin (data not shown) and mutant CaM(1,2) accumulated in the neurons to greater amounts than in untransfected cells treated with the proteasome inhibitor (Fig. 6C ). These results demonstrate that the proteasome system is involved in tightly regulating the levels of calmodulin in neurons. Immunoblot analysis of cell lysates showed that mutant CaM(1,2) also exhibited a slightly lower apparent molecular mass compared with endogenous calmodulin (Fig. 6C) . To determine whether overexpression of mutant CaM(1,2) can block the phosphorylation of Akt, we treated adeno-CaM(1,2)-infected cultures (72-h infection) with clasto-lactacystin ␤-lactone for 6 h, followed by stimulation with BDNF (25 ng/ml) for 10 min. We found that treatment with clasto-lactacystin ␤-lactone did not change the amount of Akt protein in the neurons and that Akt phosphorylation was increased to a level similar to that in control neurons stimulated by BDNF (Fig. 6, C and D) . In contrast to a requirement for functional Ca 2ϩ -binding domains 3 and 4 in BDNF-induced activation of Akt, the ability of BDNF to activate ERK1/2 was not compromised in neurons overexpressing the CaM (3, 4) or CaM(1-4) mutant (Fig. 7) .
Akt Activation by BDNF Requires Intracellular Free Calcium and Activation of PI3K, but Is Independent of CaMKs-To determine the events upstream of Akt activation in the calmodulin-mediated BDNF signaling pathway, we employed several pharmacological tools. Incubation of neurons in the presence of the intracellular Ca 2ϩ chelator BAPTA-AM significantly reduced activation of Akt by BDNF (Fig. 8A) . In contrast, the extracellular Ca 2ϩ chelator EGTA, switching the culture medium to calcium-free medium prior to BDNF stimulation, or treatment with the L-type calcium channel blocker nicardipine did not prevent activation of Akt by BDNF. These findings demonstrate a requirement for intracellular free Ca 2ϩ , but not for extracellular Ca 2ϩ , in Akt activation. Our data are consistent with a recent study showing that CaMKII can promote cell survival by directly phosphorylating and activating Akt (48) . To determine the involvement of CaMKs in Akt activation by BDNF, we employed KN-93 (a CaMKII inhibitor that selectively binds to the calmodulin-binding site of the enzyme and prevents the association of calmodulin with CaMKII), KN-92 (an inactive analog of KN-93 as a control), and AIP (a cell-permeable competitive peptide inhibitor of CaMKII). Cultures were pretreated with KN-93 and AIP at concentrations previously shown to inhibit CaMKII (49) and then stimulated with BDNF. KN-93 and AIP did not prevent activation of Akt by BDNF (Fig. 8B) , indicating that CaMKII is not required for BDNF-induced Akt activation. Because PI3K is an upstream activator of Akt in several cell survival signaling pathways, including a pathway activated by BDNF, we determined whether PI3K activation is required for Akt activation by BDNF. When cultures were pretreated with the PI3K inhibitor LY29002, the ability of BDNF to activate Akt was completely abolished (Fig. 8B) . Collectively, these findings suggest a cell survival signaling pathway in which BDNF activates Akt by a signaling pathway involving activation of calmodulin by calcium. and then stimulated with BDNF (25 ng/ml) for 10 min. The relative levels of activation of Akt kinase and p42/44 MAPKs were assessed by Western blot analysis using antibodies that selectively recognize phospho-Akt (p-Akt) and phospho-ERKs (p-Erks). The same membranes were then stripped and reprobed with antibodies against total Akt kinase and p42/44 MAPKs (phosphorylation-independent antibodies). B, 3 days after infection with adeno-␤-galactosidase (␤-gal), adenoCaM (1,2) (1, 2) , adeno-CaM (1-4) (1-4) , or adeno-CaM (3,4) (3, 4) , protein extracts were prepared to assess the phosphorylation level of Akt. C, the immunoreactive bands were quantified by densitometric analysis, and the Akt phosphorylation level was expressed as -fold of control (Con). Values are the means Ϯ S.D. of determinations made in three separate experiments. **, p Ͻ 0.01 (unpaired t test).
pathway involves PI3K and Akt, and the other involves ERK1/2. However, we found that inhibition of calmodulin prevented activation of Akt by BDNF, but did not prevent activation of ERK1/2. These findings suggest that calmodulin acts upstream of Akt in the cell survival pathway activated by BDNF. They further suggest that ERKs do not play an essential role in cell survival signaling by BDNF; and indeed, inhibition of ERKs with PD98059 did not compromise the ability of BDNF to support neuronal survival. A similar dependence of BDNF cell survival signaling on PI3K, but not on ERKs, was recently reported in a study of motor neurons (20) . The survival of sympathetic neurons induced by depolarization and calcium influx requires activation of a pathway involving Ras, PI3K, and Akt (50) . Our data are consistent with calcium/calmodulin activating a similar cell survival pathway in neocortical neurons. Based upon the prominent involvement of CaMKII and other CaMKs as mediators of biological actions of calmodulin in neurons (34), we attempted to block the neuronal survivalpromoting action of BDNF with inhibitors of CaMKII. Surprisingly, inhibition of CaMKII did not block activation of Akt induced by BDNF, suggesting that calmodulin acts on other proteins upstream of Akt. Although our data clearly show that calmodulin acts upstream of Akt, the protein(s) with which calmodulin interacts in this pathway remains to be established. Based upon recent studies of the involvement of calmodulin in insulin signaling, a site of action of calmodulin in cell survival signaling by BDNF downstream of receptor activation, but upstream of PI3K activation, seems likely. Thus, it was shown that calmodulin antagonists have no effect on insulin receptor autophosphorylation or tyrosine phosphorylation of insulin receptor substrate-1, but completely abolish insulin-induced activation of PI3K (51) . Further analyses in the latter study showed that calmodulin is essential for the formation of phosphatidylinositol 3,4,5-triphosphate. A candidate target protein for activation of PI3K by calmodulin is Ras because it has been reported that calmodulin can bind directly to Ras and modulate its downstream signaling (52) . p42/44 MAPKs can be activated by membrane depolarization and Ca 2ϩ influx through voltage-dependent L-type calcium channels in PC12 cells through initial activation of Ras (27, 28) . This Ras-MAPK pathway can also be activated by neurotrophins such as BDNF by ligand binding to a specific receptor tyrosine kinase, resulting in tyrosine autophosphorylation of the receptor and tyrosine phosphorylation of Shc (12, 53) . Previous studies suggested that Ca 2ϩ flux and activation of calmodulin is necessary for activation of the Ras-MAPK pathway in response to membrane depolarization (54, 55) ; however, whether receptor tyrosine kinase phosphorylation and the subsequent Shc-Ras-MAPK activation are calmodulin-modulated is neurotrophin-and cell type-dependent. Nerve growth factor activation of the ERK pathway in PC12 cells is modulated by Ca 2ϩ and calmodulin (56), whereas activation of ERKs by epi- dermal growth factor in the same cell type is not modulated by calmodulin (54) . In our studies of primary cortical neurons, we found that Ca 2ϩ -insensitive calmodulin mutants specifically blocked BDNF-induced Akt activation without affecting ERK activity. Our data demonstrate a novel calmodulin-mediated, but CaMK-and ERK-independent, neuronal survival signaling pathway in neocortical neurons.
The Ca 2ϩ -binding requirements for the biological activities of calmodulin in neurons had not been studied previously, although it had been shown that occupancy of all four Ca 2ϩ -binding domains is required for full activity of calmodulin in other cell types (14, 51, 56, 57) . To determine the roles of Ca 2ϩ binding in the neuronal survival-promoting function of calmodulin, we mutated critical asparagine residues in each of the Ca 2ϩ -binding domains of calmodulin. However, we observed that neurons overexpressing mutant calmodulin also expressed lower levels of wild-type calmodulin, suggesting that the forms of calmodulin with mutated calcium-binding domains interfere with the ability of endogenous calmodulin to activate Akt and to promote neuronal survival in response to BDNF. Previous studies employed co-immunoprecipitation and affinity chromatography to demonstrate that calmodulin associates with SH2 domains in the 85-kDa regulatory subunits of PI3K, thereby enhancing PI3K activity in vitro and in intact cells in the presence of calcium (57) . We found that overexpression of calmodulin with mutations in all four Ca 2ϩ -binding domains completely abolished the activation of Akt and the neuronal survival-promoting action of BDNF. It is therefore reasonable to consider a model in which calmodulin associates with the SH2 domains in the 85-kDa regulatory subunits of PI3K in unstimulated cells. In response to a stimulus such as BDNF, calcium binds to calmodulin, resulting in a conformational change required to activate PI3K. When mutant (calcium-unresponsive) forms of calmodulin are expressed in neurons, they therefore act in a dominant-negative manner by competing with wildtype calmodulin for binding to PI3K. Expression of the mutant forms of calmodulin therefore renders neurons unresponsive to BDNF. It is also possible that calcium-insensitive mutants of calmodulin compete, in a dominant-negative manner, with other calmodulin-regulated proteins such as Ras (52) .
Although disabling all four Ca 2ϩ -binding domains was expected to completely abolish the biological activities of calmodulin, we also found that disabling only the two C-terminal Ca 2ϩ -binding domains was sufficient to render calmodulin completely dysfunctional. Previous studies have shown that the C-terminal pair of EF-hands has a 3-5-fold higher affinity for Ca 2ϩ than the N-terminal pair of sites (32) . It is therefore likely that disabling the two C-terminal Ca 2ϩ -binding domains of calmodulin (CaM (3,4) ) creates a low-affinity Ca 2ϩ -binding protein that can no longer act as a Ca 2ϩ sensor and therefore fails to transduce the calcium signal to downstream effector proteins such as Akt. Our observations that overexpression of the CaM(3,4) mutant, but not the CaM(1,2) mutant, could mimic the effects of the CaM(1-4) mutant by blocking the activation of Akt (Fig. 6 ) support the latter mechanism. Collectively, our data suggest that, to activate the PI3K-Akt pathway, calcium-binding domains 3 and 4 of calmodulin are essential.
It has been reported previously that activation of TrkA leads to a small and rapid increase in [Ca 2ϩ ] i (58) , and also we observed that intracellular Ca 2ϩ was required for activation of Akt by BDNF in neocortical neurons (Fig. 8) . Because BDNFinduced activation of Akt was abolished by the intracellular Ca 2ϩ chelator BAPTA-AM, but not by the extracellular Ca 2ϩ chelator EGTA, calcium-free medium, or an L-type calcium channel blocker, it appears that BDNF signaling mobilizes an intracellular pool of Ca 2ϩ that is required for activation of calmodulin. Indeed, it was recently reported that BDNF stimulates a rapid release of Ca 2ϩ from endoplasmic reticulum stores in cerebellar granule neurons (59) .
The downstream targets of Akt that promote neuronal survival have begun to be elucidated. Activation of the PI3K-Akt pathway can increase the expression of anti-apoptotic members of the Bcl-2 family of proteins (60), can phosphorylate and thereby inactivate the pro-apoptotic protein Bad (61) , and may also act at a post-mitochondrial step to prevent caspase activation (62) . Consistent with the latter mechanisms in the neuronal survival-promoting actions of BDNF, it has been shown that BDNF induces the expression of Bcl-2 in sensory and parasympathetic neurons (63) and that BDNF blocks ischemiainduced activation of caspase-3 in cortical neurons of neonatal rats (64) . BDNF has also been shown to increase the production of antioxidant enzymes in cultured rat hippocampal neurons (65) . BDNF can also stabilize cellular calcium homeostasis, an action that may contribute to its ability to protect neurons against apoptosis (44, 65) . The latter action of BDNF is interesting in light of the present findings demonstrating a pivotal role for the Ca 2ϩ -binding protein calmodulin as a mediator of neuronal cell survival signaling. Thus, the calcium/calmodulin signal appears to activate genes that encode proteins that help neurons cope with more severe and potentially lethal stimuli. Based upon previous studies of the neuroprotective effects of BDNF, such proteins may include the calcium-binding protein calbindin (66) and glutamate receptor subunits (36) .
